clorpromazina
Clorpromazina is a first-generation antipsychotic medication primarily used in the treatment of psychotic disorders, such as schizophrenia and bipolar disorder. It belongs to the class of drugs known as phenothiazines and was first synthesized in the 1950s. Originally developed as an antiemetic, clorpromazina gained recognition for its antipsychotic effects, making it one of the foundational drugs in the field of psychiatric treatment.
The drug works primarily by blocking dopamine receptors in the brain, particularly in the mesolimbic pathway,
Common therapeutic uses include managing acute psychotic episodes, preventing relapse in schizophrenia, and treating manic episodes
However, clorpromazina is not without risks. Side effects can include extrapyramidal symptoms (such as tremors, rigidity,
Clorpromazina is generally well-tolerated when prescribed at appropriate doses, but monitoring for adverse effects is essential.